{
    "organizations": [],
    "uuid": "04471074e354bdb8b595f69d85b0dcc3aba73a6d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bellicum-pharmaceuticals-reports-q/brief-bellicum-pharmaceuticals-reports-q1-loss-per-share-of-0-68-idUSASC0A0L3",
    "ord_in_thread": 0,
    "title": "BRIEF-Bellicum Pharmaceuticals Reports Q1 Loss Per Share Of $0.68",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Bellicum Pharmaceuticals Inc:\n* BELLICUM PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS $0.68\n* Q1 EARNINGS PER SHARE VIEW $-0.69 — THOMSON REUTERS I/B/E/S\n* QTRLY GRANT REVENUE $154,000 VERSUS $128,000 * Q1 REVENUE VIEW $32860.00 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T06:46:00.000+03:00",
    "crawled": "2018-05-09T12:44:07.036+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "bellicum",
        "pharmaceutical",
        "inc",
        "bellicum",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "qtrly",
        "net",
        "loss",
        "per",
        "share",
        "attributable",
        "common",
        "shareholder",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "qtrly",
        "grant",
        "revenue",
        "versus",
        "q1",
        "revenue",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}